Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on June 10, 2008, to disclose information related to upcoming meetings with securities analysts and investors scheduled between June 11 and June 20, 2008. The primary purpose of these meetings was to reaffirm the company's full-year 2008 earnings per share (EPS) guidance that had been previously issued on April 23, 2008. This reaffirmation suggests management's confidence in achieving previously stated financial targets for the year. Investors should note that the information provided in this 8-K is subject to forward-looking statement safe harbor provisions, meaning actual results could differ due to various risks and uncertainties outlined in the filing. The company emphasized that the information is not considered 'filed' for Section 18 purposes and should not be incorporated into future SEC filings.
Key Highlights
- 1WellPoint (Elevance Health) reaffirmed its full-year 2008 EPS guidance during analyst and investor meetings.
- 2The guidance was originally provided on April 23, 2008, via press release and conference call.
- 3Upcoming meetings with analysts and investors were scheduled from June 11 to June 20, 2008.
- 4The filing explicitly states that the information is not deemed 'filed' for Section 18 of the Exchange Act.
- 5Information presented is subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
- 6The company highlighted numerous risks and uncertainties that could affect future financial performance, including regulatory changes, healthcare cost trends, competition, and Medicare/Medicaid program risks.